1. Home
  2. Companies
  3. TTX
  4. Material Events

Tetratherix (ASX:TTX) — Material Events

ASX:TTX · 10 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Significant 9 articles Notable 1 article Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
9
Tetratherix’s TetraDerm Slashes Scar Scores in Major Clinical BreakthroughMedium
Tetratherix reports promising interim clinical results for scar prevention product TetraDerm
17 Feb 2026 ·Clinical Trial Update ·85
Tetratherix Secures $5M to Accelerate Tutelix Prostate Spacer TrialMedium
Tetratherix advances Tutelix prostate spacer with $5M Series A, progressing to pivotal US-Australia trial
10 Mar 2026 ·ASX Release ·85
Tetratherix Accelerates Growth with New Partnerships and Manufacturing ExpansionMedium
Tetratherix advances clinical programs, secures strategic partnerships, and expands manufacturing with strong cash position
28 Jan 2026 ·Quarterly Activities Report ·85
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.